Adavance Life Sciences to be Featured at Venturwires'
Lifescience Portfolio Investment Conference
Company designated as one of most promising start-up biotechs
Woodridge, Ill, Oct. 17, 2002 -Advanced Life Sciences (ALS) will
be featured as one of the 100 most promising start-up private
biotech companies at VentureWire's 2002 Lifescience Portfolio
Investment Conference on Tuesday, Oct. 22, in San Francisco. Michael
T. Flavin, Ph.D., Advanced Life Sciences' CEO will present ALS
at 9:15 a.m. before an audience of investors, analysts, biotech
CEOs, journalists and representatives of large pharmaceutical
Participating companies are looking for various stages of investment
support. "This event represents a key networking opportunity
for investment-seeking biotech companies, like Advanced Life Sciences,
to showcase our technologies before an audience of investors,
analysts, biotech CEOs, journalists and representatives of large
pharmaceutical companies also from the Midwest", said Dr.
Based in Woodridge, Ill., Advanced Life Sciences, Inc. (www.advancedlifesciences.com)
is a privately held biopharmaceutical company that discovers and
develops therapeutic compounds to fight infection, inflammation
and cancer. The company bridges the gap between drug discovery
and pharmaceutical commercialization, and focuses on diseases
that have significant unmet medical needs in important markets.